Elucidating the Optimal Use of Mitigation Strategies for Improving Pancreatic Fistula Rates after Pancreatoduodenectomy

This robust experience indicates that many frequently employed fistula mitigation tactics are actually ineffective. Conversely, the optimal approaches identified herein are underutilized-in just 32% of patients. Simplified, tailored application can drive down stubborn fistula rates, enhance care, and move toward personalized medicine for fistula prevention.